Cargando…
Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China
BACKGROUND: Polyglucosan body myopathy 1 (PGBM1) is a type of glycogen storage disease that can cause skeletal muscle myopathy and cardiomyopathy with or without immunodeficiency due to a pathogenic mutation in the RBCK1 gene. PGBM1 has been reported in only 14 European and American families, and no...
Autores principales: | Chen, Lin, Wang, Nan, Hu, Wenbin, Yu, Xuen, Yang, Renming, Han, Yongzhu, Yan, Yan, Nian, Na, Sha, Congbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789478/ https://www.ncbi.nlm.nih.gov/pubmed/33413275 http://dx.doi.org/10.1186/s12891-020-03884-0 |
Ejemplares similares
-
GYG1: A distal myopathy with polyglucosan bodies
por: Nicolau, Stefan, et al.
Publicado: (2020) -
Characterization of cognitive impairment in adult polyglucosan body disease
por: Zebhauser, Paul Theo, et al.
Publicado: (2022) -
GYG1 gene mutations in a family with polyglucosan body myopathy
por: Fanin, Marina, et al.
Publicado: (2015) -
A novel variant of RBCK1 gene causes mild polyglucosan
myopathy
por: AlAnzi, Talal, et al.
Publicado: (2022) -
Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype–phenotype spectrum
por: Krenn, Martin, et al.
Publicado: (2017)